Literature DB >> 22223725

Medical male circumcision for HIV/AIDS prevention in Uganda - the cost of disposable versus re-usable circumcision kits.

Andreas Kuznik1, Mohammed Lamorde, Denis Bbaale Sekavuga, Brenda Picho, Alex Coutinho.   

Abstract

We evaluated the cost implications of medical male circumcisions for HIV prevention when performed using re-usable equipment that is sterilized after each use versus using single-use disposal kits. In Uganda, a re-usable circumcision kit results in a net saving of US$7.14-US$12.34 or 46-59%. In resource-limited settings seeking to expand access to medical male circumcision for HIV prevention, substantial cost reductions may be achieved by adopting re-usable circumcision kits.

Entities:  

Mesh:

Year:  2012        PMID: 22223725     DOI: 10.1258/td.2011.110297

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.

Authors:  Yukari C Manabe; Sabine M Hermans; Mohammed Lamorde; Barbara Castelnuovo; C Daniel Mullins; Andreas Kuznik
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

2.  Foreskin cutting beliefs and practices and the acceptability of male circumcision for HIV prevention in Papua New Guinea.

Authors:  David MacLaren; Rachael Tommbe; Tracie Mafile'o; Clement Manineng; Federica Fregonese; Michelle Redman-MacLaren; Michael Wood; Kelwyn Browne; Reinhold Muller; John Kaldor; William John McBride
Journal:  BMC Public Health       Date:  2013-09-09       Impact factor: 3.295

3.  Reach and cost-effectiveness of the PrePex device for safe male circumcision in Uganda.

Authors:  Kevin Duffy; Moses Galukande; Nick Wooding; Monica Dea; Alex Coutinho
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

4.  Systematic Monitoring of Voluntary Medical Male Circumcision Scale-up: adoption of efficiency elements in Kenya, South Africa, Tanzania, and Zimbabwe.

Authors:  Jane T Bertrand; Dino Rech; Dickens Omondi Aduda; Sasha Frade; Mores Loolpapit; Michael D Machaku; Mathews Oyango; Webster Mavhu; Alexandra Spyrelis; Linnea Perry; Margaret Farrell; Delivette Castor; Emmanuel Njeuhmeli
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.